2m 2m 2m 2m 2m 2m 2m
BioAffinity (BIAF)
NASDAQ
$7.93-$0.02 (-0.29%)
Price as of Sep 11, 2026 7:59 PM EDT- $4.8MMarket Cap
- -93.46%1-Year Change
- Diagnostics & ResearchIndustry
BioAffinity (BIAF)
$7.93-$0.02 (-0.29%)
BIAF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.95 | ||
Change | -$1.44 (-15.34%) | ||
Open | $9.96 | ||
High | $10.08 | ||
Low | $7.82 | ||
Previous Close | $9.39 | ||
Volume | 827,861 | ||
30-Day Average Volume | 7,216,260 | ||
1-Week Change | -47.94% | ||
1-Month Change | 9.05% | ||
1-Year Change | -93.46% | ||
3-Year Change | -98.94% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 600,736 | ||
Total Assets | $7.6M | ||
Market Cap | $4.8M | ||
Enterprise Value | $2.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$3.3M | ||
EBIT | $0.00 | ||
EBITDA | $61,556.00 | ||
Net Working Capital | $1.2M | ||
EPS | -$9.60 | ||
Enterprise Value/EBITDA | 39 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 08/24/2026 | ||
Earnings & Revenue